Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression

Bo Yin, Bin Peng, Ying Luo, Shanghua Fan, Ting Xiao, Xiaoli Zou, Hongjuan Dong Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of ChinaCorrespondence: Hongjuan DongDepartment of Neurology, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wucha...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yin B, Peng B, Luo Y, Fan S, Xiao T, Zou X, Dong H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	botulinum toxin type a repetitive transcranial magnetic stimulation anxiety/depression disorder benign essential blepharospasm Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/70e3636d5bc841b7b18276c3516fbb6b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:70e3636d5bc841b7b18276c3516fbb6b
record_format	dspace
spelling	oai:doaj.org-article:70e3636d5bc841b7b18276c3516fbb6b2021-12-02T17:08:57ZEfficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression1178-2021https://doaj.org/article/70e3636d5bc841b7b18276c3516fbb6b2021-08-01T00:00:00Zhttps://www.dovepress.com/efficacy-of-repetitive-transcranial-magnetic-stimulation-combined-with-peer-reviewed-fulltext-article-NDThttps://doaj.org/toc/1178-2021Bo Yin, Bin Peng, Ying Luo, Shanghua Fan, Ting Xiao, Xiaoli Zou, Hongjuan Dong Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of ChinaCorrespondence: Hongjuan DongDepartment of Neurology, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wuchang District, Wuhan, 430060, People’s Republic of ChinaTel +86-27-88999120Email dhjdhj027@sina.comObjective: To evaluate the improvement of motor, anxiety, and depression in patients with blepharospasm with the use of botulinum toxin type A (BTX-A) and repetitive transcranial magnetic stimulation (rTMS).Methods: A total of 63 BEB patients accompanied by anxiety/depression were enrolled, among which 28 patients were treated with the injection of botulinum toxin type A (BTX-A) alone, while 35 patients were treated with BTX-A injection combined with rTMS. All patients were followed up for 6 months, and the overall efficacy was evaluated.Results: BTX-A alone treatment and combined rTMS treatment could both significantly improve the symptoms of patients, and the effective rate was 92.86% and 94.29%, respectively. The duration of efficacy was significantly longer in the combined rTMS treatment group (16.89± 3.39 weeks) than in BTX-A treatment group (13.04± 3.48 weeks). After treatment, SDS score of BTX-A treatment group and combined rTMS treatment group was 49.69± 7.90 and 49.46± 6.73, respectively, and there was no significant difference between the two treatment groups; SAS score of BTX-A treatment group and combined rTMS treatment group was 53.88± 7.34 and 48.79± 6.62, respectively, and there was significant difference between the two treatment groups.Conclusion: Compared to BTX-A alone treatment, BTX-A combined with rTMS can effectively improve the effect of BTX-A, prolong the duration of blepharospasm relief, and significantly reduce depression and anxiety in patients with BEB.Keywords: botulinum toxin type A, repetitive transcranial magnetic stimulation, anxiety/depression disorder, benign essential blepharospasmYin BPeng BLuo YFan SXiao TZou XDong HDove Medical Pressarticlebotulinum toxin type arepetitive transcranial magnetic stimulationanxiety/depression disorderbenign essential blepharospasmNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 17, Pp 2707-2711 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	botulinum toxin type a repetitive transcranial magnetic stimulation anxiety/depression disorder benign essential blepharospasm Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	botulinum toxin type a repetitive transcranial magnetic stimulation anxiety/depression disorder benign essential blepharospasm Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Yin B Peng B Luo Y Fan S Xiao T Zou X Dong H Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
description	Bo Yin, Bin Peng, Ying Luo, Shanghua Fan, Ting Xiao, Xiaoli Zou, Hongjuan Dong Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of ChinaCorrespondence: Hongjuan DongDepartment of Neurology, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wuchang District, Wuhan, 430060, People’s Republic of ChinaTel +86-27-88999120Email dhjdhj027@sina.comObjective: To evaluate the improvement of motor, anxiety, and depression in patients with blepharospasm with the use of botulinum toxin type A (BTX-A) and repetitive transcranial magnetic stimulation (rTMS).Methods: A total of 63 BEB patients accompanied by anxiety/depression were enrolled, among which 28 patients were treated with the injection of botulinum toxin type A (BTX-A) alone, while 35 patients were treated with BTX-A injection combined with rTMS. All patients were followed up for 6 months, and the overall efficacy was evaluated.Results: BTX-A alone treatment and combined rTMS treatment could both significantly improve the symptoms of patients, and the effective rate was 92.86% and 94.29%, respectively. The duration of efficacy was significantly longer in the combined rTMS treatment group (16.89± 3.39 weeks) than in BTX-A treatment group (13.04± 3.48 weeks). After treatment, SDS score of BTX-A treatment group and combined rTMS treatment group was 49.69± 7.90 and 49.46± 6.73, respectively, and there was no significant difference between the two treatment groups; SAS score of BTX-A treatment group and combined rTMS treatment group was 53.88± 7.34 and 48.79± 6.62, respectively, and there was significant difference between the two treatment groups.Conclusion: Compared to BTX-A alone treatment, BTX-A combined with rTMS can effectively improve the effect of BTX-A, prolong the duration of blepharospasm relief, and significantly reduce depression and anxiety in patients with BEB.Keywords: botulinum toxin type A, repetitive transcranial magnetic stimulation, anxiety/depression disorder, benign essential blepharospasm
format	article
author	Yin B Peng B Luo Y Fan S Xiao T Zou X Dong H
author_facet	Yin B Peng B Luo Y Fan S Xiao T Zou X Dong H
author_sort	Yin B
title	Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
title_short	Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
title_full	Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
title_fullStr	Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
title_full_unstemmed	Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
title_sort	efficacy of repetitive transcranial magnetic stimulation combined with botulinum toxin type a for benign essential blepharospasm patients accompanied by anxiety and depression
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/70e3636d5bc841b7b18276c3516fbb6b
work_keys_str_mv	AT yinb efficacyofrepetitivetranscranialmagneticstimulationcombinedwithbotulinumtoxintypeaforbenignessentialblepharospasmpatientsaccompaniedbyanxietyanddepression AT pengb efficacyofrepetitivetranscranialmagneticstimulationcombinedwithbotulinumtoxintypeaforbenignessentialblepharospasmpatientsaccompaniedbyanxietyanddepression AT luoy efficacyofrepetitivetranscranialmagneticstimulationcombinedwithbotulinumtoxintypeaforbenignessentialblepharospasmpatientsaccompaniedbyanxietyanddepression AT fans efficacyofrepetitivetranscranialmagneticstimulationcombinedwithbotulinumtoxintypeaforbenignessentialblepharospasmpatientsaccompaniedbyanxietyanddepression AT xiaot efficacyofrepetitivetranscranialmagneticstimulationcombinedwithbotulinumtoxintypeaforbenignessentialblepharospasmpatientsaccompaniedbyanxietyanddepression AT zoux efficacyofrepetitivetranscranialmagneticstimulationcombinedwithbotulinumtoxintypeaforbenignessentialblepharospasmpatientsaccompaniedbyanxietyanddepression AT dongh efficacyofrepetitivetranscranialmagneticstimulationcombinedwithbotulinumtoxintypeaforbenignessentialblepharospasmpatientsaccompaniedbyanxietyanddepression
_version_	1718381503335890944

Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression

Ejemplares similares